Carl F. Mauch

Investor Relations Contact bij TCR2 THERAPEUTICS INC.

Health Technology

Finance

Actieve functies van Carl F. Mauch

Bedrijven	Functie	Begin	Einde
TCR2 THERAPEUTICS INC.	Investor Relations Contact	-	-
TCR2 THERAPEUTICS INC.	Public Communications Contact	-	-
ITEOS THERAPEUTICS, INC.	Investor Relations Contact	-	-
ITEOS THERAPEUTICS, INC.	Public Communications Contact	-	-
Stern Investor Relations, Inc. Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY.	Directeur/Bestuurslid	01-01-2016	-

Internationaal

Verenigde Staten

Operationeel

Public Communications Contact	2
Investor Relations Contact	2
Director/Board Member	1

Sectoraal

Health Technology	3
Finance	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
ITEOS THERAPEUTICS, INC.	Health Technology

Bedrijven in privébezit	2
Stern Investor Relations, Inc. Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY.	Finance
TCR2 Therapeutics, Inc. TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA.	Health Technology

Bedrijven in privébezit

Finance

Health Technology